Back to News
Market Impact: 0.18
Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR
Source: GlobeNewswire
Healthcare & BiotechTechnology & Innovation
AACR Conference on Pancreatic Cancer data indicate that Annamycin's antitumor activity is partially mediated by CD8+ T cells. The findings support a potential immune-mediated mechanism in addition to the drug's direct cytotoxic effects, providing encouraging preclinical rationale for its development.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- OpenAI rogue agents leaked 53 images from ChatGPT users and reportedly created nearly 1 million links packing encoded bits of info
- Arming Taiwan an important US interest, Taipei official says after Trump-Xi summit
- Shares of Akamai surge after deal with Anthropic. What Wall Street is saying
- Anthropic Goes Big on Compute, Microsoft Rethinks AI
- Microsoft gives Copilot a much-needed overhaul, and the stock deservedly soars
- Wall Street Week | China’s Trade Reckoning, Syracuse’s Second Chance, Humanoids in Healthcare